Cargando…
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
Several studies highlight a key involvement of endocannabinoid (EC) system in autism pathophysiology. The EC system is a complex network of lipid signaling pathways comprised of arachidonic acid-derived compounds (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), their G-protein-coupled receptors...
Autores principales: | Brigida, Anna Lisa, Schultz, Stephen, Cascone, Mariana, Antonucci, Nicola, Siniscalco, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535916/ https://www.ncbi.nlm.nih.gov/pubmed/28671614 http://dx.doi.org/10.3390/ijms18071425 |
Ejemplares similares
-
Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
por: Siniscalco, Dario, et al.
Publicado: (2018) -
Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
por: Schultz, Stephen, et al.
Publicado: (2021) -
Stem Cell-Derived Exosomes in Autism Spectrum Disorder
por: Alessio, Nicola, et al.
Publicado: (2020) -
Speech-Stimulating Substances in Autism Spectrum Disorders
por: Castillo, María Andrea, et al.
Publicado: (2019) -
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)